Association between markers of emphysema and more severe chronic obstructive pulmonary disease

Thorax

Volumn 61, Issue 12, 2006, Pages 1037-1042

  Boschetto, P ^a,b   Quintavalle, S ^b   Zeni, E ^b   Leprotti, S ^b   Potena, A ^c   Ballerin, L ^c   Papi, A ^b   Palladini, G ^d   Luisetti, M ^d   Annovazzi, L ^d   Iadarola, P ^d   De Rosa, E ^b   Fabbri, L M ^e   Mapp, C E ^b  

^a Dipartimento di Medicina Clinica e Sperimentale   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; DESMOSINE; ELASTIN; GELATINASE B; GLUCOCORTICOID; LEUKOCYTE ELASTASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

AIRWAY OBSTRUCTION; ARTICLE; BODY MASS; CELL COUNT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG TOLERABILITY; DYSPNEA; EMPHYSEMA; EXERCISE; FORCED EXPIRATORY VOLUME; HUMAN; INSPIRATORY CAPACITY; LUNG FUNCTION TEST; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; OUTPATIENT CARE; PRIORITY JOURNAL; RATING SCALE; SPUTUM ANALYSIS; TOTAL LUNG CAPACITY; URINALYSIS;

AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; CELL COUNT; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; SPUTUM; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TOMOGRAPHY, X-RAY COMPUTED; TOTAL LUNG CAPACITY; VITAL CAPACITY;

EID: 33845195875     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2006.058321     Document Type: Article

References (46)

1. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care Med 2001;163:1256-76.
2. Boschetto P, Miniati M, Miotto D, et al. Predominant emphysema phenotype in chronic obstructive pulmonary disease patients. Eur Respir J 2003;21:450-4.
3. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-12.
4. Casanova C, Cote C, de Torres JP, et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;171:591-7.
5. Burrows B, Bloom JW, Traver GA, et al. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med 1987;317:1309-14.
6. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003;22:672-88.
7. Shapiro SD. Proteinases in chronic obstructive pulmonary disease. Biochem Soc Trans 2002;30:98-102.
8. Gevenois PA, Scillia P, de Maertelaer V, et al. The effects of age, sex, lung size, and hyperinflation on CT lung densitometry. AJR 1996;167:1169-73.
9. Madani A, Keyzer C, Gevenois PA. Quantitative computed tomography assessment of lung structure and function in pulmonary emphysema. Eur Respir J 2001;18:720-30.
10. Siafakas NM, Vermeire P, Pride NB, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J 1995;8:1398-420.
11. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993;16:5-40.
12. Cotes JE, Chinn DJ, Quanjer PH, et al. Standardization of the measurement of transfer factor (diffusing capacity). Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993;16:41-52.
13. Rytila PH, Lindqvist AE, Laitinen LA. Safety of sputum induction in chronic obstructive pulmonary disease. Eur Respir J 2000;15:1116-9.
14. Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-75.
15. Kleiner DE, Stetler-Stevenson WG. Quantitative zymography: detection of picogram quantities of gelatinases. Anal Biochem 1994;218:325-9.
16. Vignola AM, Riccobono L, Mirabella A, et al. Sputum metalloproteinase-9/ tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med 1998;158:1945-50.
17. Viglio S, Luisetti M, Zanaboni G, et al. Simultaneous determination of Pseudomonas aeruginosa elastase, human leukocyte elastase and cathepsin G activities by micellar electrokinetic chromatography. J Chromatogr A 1999;846:125-34.
18. Annovazzi L, Viglio S, Perani E, et al. Capillary electrophoresis with laser-induced fluorescence detection as a novel sensitive approach for the analysis of desmosines in real samples. Electrophoresis 2004;25:683-91.
19. Annovazzi L, Viglio S, Gheduzzi D, et al. High levels of desmosines in urine and plasma of patients with pseudoxanthoma elasticum. Eur J Clin Invest 2004;34:156-64.
20. American Thoracic Society/European Respiratory Society. Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2003;168:818-900.
21. Armitage P, Berry G. Statistical methods in medical research, 3rd ed. Oxford: Blackwell, 1994.
22. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest 1988;93:580-6.
23. Ma S, Lieberman S, Turino GM, et al. The detection and quantitation of free desmosine and isodesmosine in human urine and their peptide-bound forms in sputum. Proc Natl Acad Sci USA 2003;100:12941-3.
24. Muller NL, Staples CA, Miller RR, et al. "Density mask". An objective method to quantitate emphysema using computed tomography. Chest 1988;94:782-7.
25. Cerveri I, Dore R, Corsico A, et al. Assessment of emphysema in COPD: a functional and radiologic study. Chest 2004;125:1714-8.
26. American Thoracic Society. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-7.
27. Hogg JC, Senior RM. Chronic obstructive pulmonary disease - 2: Pathology and biochemistry of emphysema. Thorax 2002;57:830-4.
28. Finlay GA, Russell KJ, McMahon KJ, et al. Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients. Thorax 1997;52:502-6.
29. Finlay GA, O'Driscoll LR, Russell KJ, et al. Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med 1997;156:240-7.
30. Saetta M, Turato G, Maestrelli P, et al. Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:1304-9.
31. Gross P, Pfitzer EA, Tolker E, et al. Experimental emphysema: its production with papain in normal and silicotic rats. Arch Environ Health 1965;11:50-8.
32. Laurell CB, Eriksson S. The electrophoretic alpha 1-globulin pattern of serum in alpha 1-antitrypsin deficiency. Scand J Clin Lab Invest 1963;15:132-40.
33. Damiano VV, Tsang A, Kucich U, et al. Immunolocalization of elastase in human emphysematous lungs. J Clin Invest 1986;78:482-93.
34. Fox B, Bull TB, Guz A, et al. Is neutrophil elastase associated with elastic tissue in emphysema? J Clin Pathol 1988;41:435-40.
35. Ohnishi K, Takagi M, Kurokawa Y, et al. Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. Lab Invest 1998;78:1077-87.
36. 1-antitrypsin deficiency (PiZ). Am J Respir Crit Care Med 1999;160:1968-75.
37. Stone PJ, Gottlieb DJ, O'Connor GT, et al. Elastin and collagen degradation products in urine of smokers with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;151:952-9.
38. Viglio S, Iadarola P, Lupi A, et al. MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients. Eur Respir J 2000;15:1039-45.
39. Gottlieb DJ, Stone PJ, Sparrow D, et al. Urinary desmosine excretion in smokers with and without rapid decline in lung function: the Normative Aging Study. Am J Respir Crit Care Med 1996;154:1290-5.
40. Cocci F, Miniati M, Monti S, et al. Urinary desmosine excretion is inversely correlated with the extent of emphysema in patients with chronic obstructive pulmonary disease. Int J Biochem Cell Biol 2002;34:594-604.
41. Postma DS, Boezen HM. Rationale for the Dutch hypothesis. Chest 2004;126:96-104S.
42. Jindal SK. Dutch hypothesis. Chest 2004;126:329-30.
43. Turato G, Zuin R, Saetta M. Pathogenesis and pathology of COPD. Respiration 2001;68:117-28.
44. Fujimoto K, Yasuo M, Urushibata K, et al. Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease. Eur Respir J 2005;25:640-6.
45. Rosenbluth DB, Shapiro SD, Hogg JC, et al. Expression of the mRNA for the 92 kD gelatinase is increased in emphysema (abstract). Am J Respir Crit Care Med 1995;151:A529.
46. Okada S, Kita H, George TJ, et al. Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9. Am J Respir Cell Mol Biol 1997;17:519-28.